Skip to main content
OpenTrials
Completed

NCT Number: NCT05175599

Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes

This study aims to explore outcomes of waterbirth in comparison to conventional land birth for low-risk healthy women and neonates in a hospital setting in Milwaukee, WI. This study hypothesizes that women who labor and birth in water will use less pain medication, have a shorter labor, will be more likely to initiate breastfeeding prior to discharge, will not experience more negative outcomes, and will experience greater satisfaction than women who labor and birth on land.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Aurora Sinai Medical Center

Milwaukee, Wisconsin, 53233, United States

About this study

Women eligible for a waterbirth will be randomized (2:1) to either waterbirth or land birth at the beginning of the third trimester (25 weeks 0 days to 34 weeks 0 days gestation). The investigators recognize that some women will risk-out or opt-out because of the unpredictability of labor and birth. The goal is that approximately 50% of enrolled waterbirth participants give birth in water. Additionally, the investigators aim to approach the majority of patients eligible for waterbirth with the understanding that some women will not want to participate in a research study. Please note that given the variable nature of birth, once a woman is randomized and enrolled to either group, an intention to treat model will be used for analysis. Following birth, women will be asked to complete a validated questionnaire to evaluate maternal satisfaction prior to discharge. Other data will be collected from our electronic medical record or 4-8 weeks postpartum.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prenatal low-risk, healthy, adult women (greater than or equal to 18 years of age), including:
  • Able to speak and understand English
  • Women with a singleton gestation
  • Able to ambulate with no mobility restrictions (i.e., no difficulty getting from seated to standing)
  • Less than class III obesity (BMI <40kg/m squared) at initiation of prenatal care
  • No active infections such as HIV, Hepatitis B, Hepatitis C, herpes simplex virus outbreak (on prophylaxis acceptable), group B strep positive is acceptable
  • No pre-existing medical conditions such as: heart disease, uncontrolled asthma, diabetes of any type, chronic hypertension, or other condition that requires continuous observation and/or activity restrictions
  • No high-risk pregnancy conditions: including preeclampsia, gestational hypertension, preterm gestation, multiple gestation, substance abuse, placental abruption or other unexplained vaginal bleeding, previous cesarean section, suspected fetal macrosomia (>4500gm) or intrauterine growth restrictions (<10th percentile), or other condition that requires continuous observation and/or activity restrictions

Labor inclusion criteria:

  • Greater than 37 weeks and less than 42 completed weeks gestation in vertex presentation
  • Not hypertensive or febrile (two blood pressures 140/90 four hours apart; two fevers of over 100.4 one hour apart)
  • Category 1 fetal heart tones (obtained on a 20-minute admission external fetal monitor strip)
  • Amniotic sac may be intact or ruptured. If ruptured, amniotic fluid must be clear.

Exclusion criteria

  • Women will be excluded from the study if they do not meet above inclusion criteria or they will be further excluded under the following circumstances:
  • Known need for cesarean section
  • Participant may be excluded from the study at any time at the discretion of the birth attendant (reason for study exclusion will be documented but will remain in the study group previously selected based on intention to treat).

Treatment and study plan

Water Birth

Other

The water birth group will use a tub of a water to labor and give birth.

Primary outcomes

  1. Number of Women Using Intravenous Narcotic Analgesia and Epidural Anesthesia

    Time frame: Time of admission to birth of the baby

    The number of women in the waterbirth cohort who use IV narcotic and epidural anesthesia compared with the land birth cohort.

Secondary outcomes

  1. Median Time of Labor Duration

    Time frame: Time of labor onset to time of birth

    The median time of labor duration (1st stage onset of strong regular contractions resulting in cervical change, 2nd stage pushing and birth of the neonate, 3rd stage delivery of the placenta) of women in the waterbirth cohort will be compared to the land birth cohort.

  2. United States Birth Satisfaction Scale-Revised (US-BSS-R) Score

    Time frame: Up to 72 hours post delivery

    The US-BSS-R is a 10 question scale using a 5 point Likert scale with answers ranging from "strongly agree" to "strongly disagree". The overall US-BSS-R total birth satisfaction score ranging from 0-40 (least birth satisfaction - most birth satisfaction). Women in the waterbirth cohort will be compared to those in the land birth cohort for overall US-BSS-R score.

  3. Number of Reported Maternal Adverse Outcomes

    Time frame: During labor and birth through the immediate postpartum hospital admission (24-48 hours after the birth)

    The number of women in the waterbirth cohort with reported adverse maternal obstetric outcomes will be compared to the land birth cohort.

  4. Number of Patients Breastfeeding

    Time frame: Measured from birth (immediate) through discharge from hospital (24-48 hours)

    The number of women in the waterbirth cohort who initiate immediately after the birth breastfeeding will be compared to those in the land birth cohort.

  5. Number of Neonatal Adverse Outcomes

    Time frame: Immediately after the birth until the time of the postpartum visit (usually 4 to 6 weeks of life)

    The number of patients with neonates in the waterbirth cohort with reported adverse birth outcomes will be compared to patients with neonates in the land birth cohort.

  6. Number of Patients With Neonates With Instrumental and Cesarean Deliveries

    Time frame: Time of labor to time of delivery

    The number of patients with neonates in the waterbirth cohort with instrumental and cesarean deliveries will be compared to patients with neonates in the land birth cohort.

  7. Number of Patients With Skin-to-skin Contact

    Time frame: Measured from time of birth (hour/minute) to time of skin-to-skin contact initiation (in number of minutes) up to 60 minutes of life.

    The number of patients with neonates in the waterbirth cohort with skin-to-skin contact will be compared with patients with neonates in the land birth cohort.

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Registry information

Official study title

Hospital Waterbirth: A Pilot Randomized Control Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 4, 2022
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.